News

Celsius42 and Lootah Group enter into strategic alliance

Medical technology on track for further expansion Celsius42 GmbH, one of the leading manufacturers of hyperthermia systems for use in oncology, has entered into a far-reaching, long-term strategic…

find out more

The DEGRO demands: Exploit the therapeutic advantage of hyperthermia in addition to radiotherapy!

Current DEGRO press release of 20 February 2019 The DEGRO demands: Exploit the therapeutic advantage of hyperthermia in addition to radiotherapy! In the case of defined forms of cancer, including…

find out more

Thomas Muffler died unexpectedly

It is with great regret that we inform you that Thomas Muffler has died unexpectedly. Thomas Muffler was one of the original initiators in the foundation of Celsius42+ and in the early years also its…

find out more

Treatment of liver tumors and metastases using local hyperthermia

Liver tumors or especially metastases in the liver are a frequent occurrence of tumors. There has been developed a wide range of therapeutic options here. In addition to the mostly minimally invasive…

find out more

Contact

Celsius42 GmbH
Hermann-Hollerith-Str. 11
52249 Eschweiler
Deutschland

+49 (0) 24 03 – 7829 230
Send email

Celsius42 Korea LTD
Gunpo IT-Valley, S-B102, 17, Gosan-ro 148 Beon-gil,
Gunpo-city, Gyunggi-do,
South Korea

+82-70-5208 7622
Send email

Information

Medical Blog
Sources
FAQ